This led to a specific limitation of IL-1β production, potentially impairing IL-1–driven inflammatory flares, while maintaining IL-18 release and a basal innate immune activation in CAPS, which is crucial for protection against pathogens. Here, IL1A is linked to cryopyrin-associated periodic syndrome.